OPRL1 and melanoma: Compared with vehicle-treated mice, SB612111 further intensified thermal hypersensitivity, peaking on day 11 post-inoculation (Fig. 4E–F) suggesting an active N/OFQ:OPRL1 signal ongoing during melanoma progression.